Boston, MA 10/09/2014 (wallstreetpr) – On 8th October, Trio-Tech International (NYSEMKT:TRT) announced results from its fourth quarter and year ending operations for fiscal year 2014. It reported a 10.2 percent increase in its revenue for the quarter, as against 4Q13 compare. 4Q14 revenue came in at $9.38 million. For FY14, revenue came in at $36.2 million. This was a 14.1 percent increase as against FY13 compare. Net income too was up for the reporting quarter. It came in at 7 cents per share, as against the one cent it had reported in 4Q13. For full year, net income came in at 1 cent per share as against the loss of 31 cents it had reported in FY13.
A day after sapphire glass maker GT Advanced Technologies Inc (NASDAQ:GTAT) filed for bankruptcy protection, its biggest customer and business partner Apple Inc. (NASDAQ:AAPL) released a press release on 8th October. The press release noted that it was caught unaware by the announcement and has indicated that it is evaluating its next steps as a result. The maker of iPhones has invested heavily in this particular vendor over the past few years. It has committed itself to partially pay for the Arizona factory being set up by GT Advanced Technologies Inc (NASDAQ:GTAT). The factory is being set up by the glass maker, so that it can meet the growing demand for scratch-resistant sapphire glass from Apple Inc. (NASDAQ:AAPL). The statement also indicated that it is working with the management team of the glass manufacturer to determine its next steps.
Shares of biotechnology firm Northwest Biotherapeutics, Inc (NASDAQ:NWBO) slipped downwards by nearly 7.7 percent during trading on 8th October on the back of previous day’s news that the firm had gone in for a discounted sale of its common shares to raise $11.5 million to a unnamed institutional investor. The newly issued common shares were sold at $5.05, which translated to a discount over 6th October prevailing share price.
